Scotiabank Forecasts Reduced Earnings for SNC-Lavalin Group

SNC-Lavalin Group Inc. (TSE:ATR) – Equities research analysts at Scotiabank cut their FY2026 earnings per share estimates for SNC-Lavalin Group in a report released on Thursday, March 5th. Scotiabank analyst J. Goldman now expects that the company will post earnings of $3.79 per share for the year, down from their prior estimate of $5.01. Scotiabank also issued estimates for SNC-Lavalin Group’s FY2027 earnings at $4.58 EPS.

SNC-Lavalin Group Stock Performance

SNC-Lavalin Group Company Profile

AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions.